Company Profiles

driven by the PitchBook Platform

Mersana Therapeutics

Description

Developer of biodegradable and bio inert material for drug protection. The company's products conjugate for the treatment of multiple tumor types and various preclinical oncology compounds.

2001

Founded

PRIVATE

Status

51-200

Employees

Series C1

Latest Deal Type

$33.1M

Latest Deal Amount

$149M

Total Amount Raised

Description

Developer of biodegradable and bio inert material for drug protection. The company's products conjugate for the treatment of multiple tumor types and various preclinical oncology compounds.

Website:

www.mersana.com

Formerly Known As

Nanopharma

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

840 Memorial Drive Cambridge, MA 02139United States +1 (617) 498-0020
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Mersana Therapeutics's full profile, request a free trial.

Mersana Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Mersana Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Mersana Therapeutics Investors (15)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Arrowpoint PartnersAsset ManagerMinority000 0000000 0000
Cape Family FundOtherMinority000 0000000 0000
Cormorant Asset ManagementHedge FundMinority000 0000000 0000
Elliott SigalAngel (individual)Minority000 0000000 0000
F-Prime Capital PartnersVenture CapitalMinority000 0000000 0000
Arrowpoint Partners Asset Manager
Cape Family Fund Other
Cormorant Asset Management Hedge Fund
Elliott Sigal Angel (individual)
F-Prime Capital Partners Venture Capital

Mersana Therapeutics Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Anna ProtopapasPresident, Chief Executive Officer & Board Member
Timothy Lowinger Ph.DChief Scientific Officer & Senior Vice President
Eva JackChief Business Officer
Michael Kaufman Ph.DSenior Vice President of Chemistry, Manufacturing and Controls
Wayne FosterVice President, Finance
Anna Protopapas President, Chief Executive Officer & Board Member
Timothy Lowinger Ph.D Chief Scientific Officer & Senior Vice President
Eva Jack Chief Business Officer
Michael Kaufman Ph.D Senior Vice President of Chemistry, Manufacturing and Controls
Wayne Foster Vice President, Finance

Mersana Therapeutics Board Members (10)

NameRepresentingRoleSinceContact
Info
Anna ProtopapasMersana TherapeuticsPresident, Chief Executive Officer & Board Member000 0000
David MottNew Enterprise AssociatesGeneral Partner000 0000
Elaine Jones Ph.DPfizer Venture InvestmentsExecutive Director000 0000
Jay MoorinProQuest InvestmentsFounding General Partner000 0000
Joyce Tsang Ph.DProQuest InvestmentsPartner000 0000
Anna Protopapas President, Chief Executive Officer & Board Member Mersana Therapeutics
David Mott General Partner New Enterprise Associates
Elaine Jones Ph.D Executive Director Pfizer Venture Investments
Jay Moorin Founding General Partner ProQuest Investments
Joyce Tsang Ph.D Partner ProQuest Investments
Request full access to PitchBook